Stryker SYK
NYSE SYK
$325.18 -0.69 (-0.21%)
As of: Nov 9, 2026 · 10:29 AM EST

Stryker (SYK) Gains from Sales and Divestitures (2009 - 2010)

Updated

Analysis

Stryker (SYK) Gains from Sales and Divestitures (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.72 Bn 236.23 Bn 5.13 Bn
2 Abbott Laboratories 189.64 Bn 163.50 Bn 7.39 Bn
3 Danaher 162.60 Bn 142.26 Bn 3.84 Bn
4 Intuitive Surgical 159.47 Bn 139.76 Bn 2.08 Bn
5 Medtronic 130.12 Bn 95.37 Bn 6.34 Bn
6 Stryker 124.71 Bn 110.89 Bn 4.25 Bn
7 Boston Scientific 63.08 Bn 58.52 Bn 3.43 Bn
8 Edwards Lifesciences 59.73 Bn 42.93 Bn 1.35 Bn
9 Becton Dickinson 58.27 Bn 55.42 Bn 2.32 Bn
10 Agilent Technologies 49.72 Bn 42.61 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 24.00 Mn
Dec 31, 2009 -1.70 Mn
Sep 30, 2009 -700,000.00
API Access

Stryker Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SYK&period=max&api_key=YOUR_API_KEY